Boehringer Ingelheim Pharmaceuticals, Inc.
Who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Boehringer Ingelheim Pharmaceuticals, Inc.
California lobbying records
Bills it lobbied on8 of 60
SB 598 Biosimilars3 reports · VetoedAB 1788 Pesticides: use of second generation anticoagulant rodenticides3 reports · Became lawSB 17 Health care: prescription drug costs3 reports · Became lawSB 671 Pharmacy: biological product3 reports · Became lawAB 265 Prescription drugs: prohibition on price discount3 reports · Became lawSB 26 Hazardous waste: household hazardous waste collection facility: small quantity generators3 reports · FailedSB 1206 Hydrofluorocarbon gases: sale or distribution3 reports · Became lawACR 62 Relative to chronic obstructive pulmonary disease3 reports · Became lawEvery link on this map
The same connections as a table, with the reason each one is here.
| SB 598 | Bills it lobbied on | Boehringer Ingelheim Pharmaceuticals, Inc. named SB 598, “Biosimilars”, in 3 lobbying reports. | 3 reports |
| AB 1788 | Bills it lobbied on | Boehringer Ingelheim Pharmaceuticals, Inc. named AB 1788, “Pesticides: use of second generation anticoagulant rodenticides”, in 3 lobbying reports. | 3 reports |
| SB 17 | Bills it lobbied on | Boehringer Ingelheim Pharmaceuticals, Inc. named SB 17, “Health care: prescription drug costs”, in 3 lobbying reports. | 3 reports |
| SB 671 | Bills it lobbied on | Boehringer Ingelheim Pharmaceuticals, Inc. named SB 671, “Pharmacy: biological product”, in 3 lobbying reports. | 3 reports |
| AB 265 | Bills it lobbied on | Boehringer Ingelheim Pharmaceuticals, Inc. named AB 265, “Prescription drugs: prohibition on price discount”, in 3 lobbying reports. | 3 reports |
| SB 26 | Bills it lobbied on | Boehringer Ingelheim Pharmaceuticals, Inc. named SB 26, “Hazardous waste: household hazardous waste collection facility: small quantity generators”, in 3 lobbying reports. | 3 reports |
| SB 1206 | Bills it lobbied on | Boehringer Ingelheim Pharmaceuticals, Inc. named SB 1206, “Hydrofluorocarbon gases: sale or distribution”, in 3 lobbying reports. | 3 reports |
| ACR 62 | Bills it lobbied on | Boehringer Ingelheim Pharmaceuticals, Inc. named ACR 62, “Relative to chronic obstructive pulmonary disease”, in 3 lobbying reports. | 3 reports |
| Cathleen Galgiani | Lawmakers it funded or lobbied | Cathleen Galgiani leads 1 bill Boehringer Ingelheim Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| Ed Hernandez | Lawmakers it funded or lobbied | Ed Hernandez leads 1 bill Boehringer Ingelheim Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| Jerry Hill | Lawmakers it funded or lobbied | Jerry Hill leads 2 bills Boehringer Ingelheim Pharmaceuticals, Inc. lobbied on. | Leads 2 of these bills |
| Jim Wood | Lawmakers it funded or lobbied | Jim Wood leads 1 bill Boehringer Ingelheim Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| Joseph Simitian | Lawmakers it funded or lobbied | Joseph Simitian leads 1 bill Boehringer Ingelheim Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| Nancy Skinner | Lawmakers it funded or lobbied | Nancy Skinner leads 1 bill Boehringer Ingelheim Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| Richard Bloom | Lawmakers it funded or lobbied | Richard Bloom leads 1 bill Boehringer Ingelheim Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |